SCHEMBL19863526

SCHEMBL19863526

c1ccc(-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2cc(-n3c4ccccc4c4ccccc43)cc(-n3c4ccccc4c4ccccc43)c2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.75
KDM4E B2RXH2 1/20 0.75
ATM Q13315 1/20 0.75
MAPK1 P28482 1/20 0.42
KMT2A Q03164 3/20 0.41
MAPK8 P45983 2/20 0.41
IL1R1 P14778 1/20 0.41
PGR P06401 2/20 0.41
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 2/20 0.40
MAPK9 P45984 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
KDR P35968 1/20 0.40
TSHR P16473 2/20 0.39
POLB P06746 1/20 0.39
BRCA1 P38398 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FOLH1 Q04609 1/20 0.38
GPR3 P46089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2754616 1.00 L3MBTL1 (0.75) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL1638441 0.96 L3MBTL1 (0.82) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL27426967 0.96 L3MBTL1 (0.82) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL10027565 0.94 L3MBTL1 (0.72) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL10027573 0.94 L3MBTL1 (0.72) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL19769451 0.94 L3MBTL1 (0.72) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL17228229 0.94 L3MBTL1 (0.78) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL1639366 0.94 L3MBTL1 (0.78) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL18383230 0.94 L3MBTL1 (0.78) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL12690884 0.94 KDM4E (0.62) L3MBTL1KDM4EATMMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2020-03-24 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 L3MBTL1 4752/4885KDM4E 4718/4885ATM 4443/4885
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 L3MBTL1 4752/4885KDM4E 4718/4885ATM 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.